Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia

NCT03973450 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-09-08

No results posted yet for this study

Summary

The study aims to update current knowledge about the epidemiology of pituitary tumours (PiT), based on the wide body of scientific literature on new familial and/or syndromic forms. Although inherited predisposition is increasingly recognized, its clinical relevance in unselected series of PiT patients has not been specifically addressed. In addition, it is likely that further recognition of peculiar associations between PiT and other endocrine and/or non-endocrine neoplasia will further increase the spectrum of syndromic forms. Since the identification of inherited forms of PiT may have significant clinical implications in terms of patients management and familial screening, we aim to collect any relevant information in order to estimate their prevalence in a large unselected series of PiT patients and provide new clues for a modern clinical approach to these patients.

Conditions

  • Pituitary Tumor
  • Endocrine Neoplasia
  • Hyperparathyroidism
  • Solid Tumor
  • Familial Tumor Syndrome

Interventions

OTHER

Registration of familial forms and associated neoplasia

Retrospective registration of associated endocrine and non-endocrine neoplasia and potential familial setting

Sponsors & Collaborators

  • Neuromed IRCCS

    lead OTHER

Principal Investigators

  • Marie-Lise Jaffrain-Rea, MD · Neuromed IRCCS, Pozzilli (IS), Italy

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-15
Primary Completion
2021-11-30
Completion
2022-02-28

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03973450 on ClinicalTrials.gov